Jump to main content
博士論文

An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function

Persistent ID (NDL)
info:ndljp/pid/11456690
Material type
博士論文
Author
Maimaitili Yimamu
Publisher
Maimaitili Yimamu
Publication date
2019
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
神戸大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
Maimaitili Yimamu
Publication, Distribution, etc.
Publication Date
2019
Publication Date (W3CDTF)
2019
Alternative Title
mTORC1/2キナーゼ阻害剤はリソソーム活性化を介してgemtuzumab ozogamicinの殺細胞効果を増強する
Degree grantor/type
神戸大学
Date Granted
2019-03-25
Date Granted (W3CDTF)
2019-03-25